Percutaneous coronary intervention (PCI) is increasingly used for revascularization of unprotected left main coronary artery disease. Whether intravascular ultrasonographic (IVUS) guidance during ...

Aspirin is considered the cornerstone of secondary prevention of coronary artery disease. However, the evidence supporting aspirin was largely generated before the advent of modern pharmacological and ...

Older patients with CAD scheduled for TAVR have comparable outcomes regardless of whether they undergo PCI before TAVR.

High-risk patients with left ventricular dysfunction fare as well, or better, without the support of a microaxial flow pump ...

Boston Scientific today shared new findings supporting intravascular ultrasound (IVUS)-guided percutaneous coronary ...

BACKGROUND: Adherence to the clinical performance measures has been advocated in ST-segment–elevation acute myocardial ...

Assessing intermediate coronary lesions with an intracoronary pressure wire improves clinical outcomes in patients undergoing cardiac catheterization and percutaneous coronary intervention (PCI).

Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusio ...

Percutaneous coronary intervention successfully alleviated chest pain symptoms in select patients with chronic total occlusion and reduced the frequency of anginal events, a speaker ...

Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN ...

PRO-TAVI trial shows net clinical benefit compared with PCI before valve replacement ...

Coronary artery disease frequently accompanies severe aortic stenosis and is identified in up to half of patients referred for transcatheter aortic valve implantation (TAVI).1 Yet the optimal ...